REPLIGEN CORP — Director's Dealing 2015

Nov 12, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2015-11-09

Reporting Person: COOPER GLENN L MD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-09	Common Stock	A	1000	$26.5635	Acquired	35331	Direct

Footnotes

F1: $26.5635 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.55 to $26.5951, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.